1. Home
  2. NOTV vs PNF Comparison

NOTV vs PNF Comparison

Compare NOTV & PNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • PNF
  • Stock Information
  • Founded
  • NOTV 1974
  • PNF 2001
  • Country
  • NOTV United States
  • PNF United States
  • Employees
  • NOTV N/A
  • PNF N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • PNF Finance Companies
  • Sector
  • NOTV Health Care
  • PNF Finance
  • Exchange
  • NOTV Nasdaq
  • PNF Nasdaq
  • Market Cap
  • NOTV 62.5M
  • PNF 55.0M
  • IPO Year
  • NOTV 1997
  • PNF N/A
  • Fundamental
  • Price
  • NOTV $2.00
  • PNF $6.93
  • Analyst Decision
  • NOTV Strong Buy
  • PNF
  • Analyst Count
  • NOTV 1
  • PNF 0
  • Target Price
  • NOTV $5.00
  • PNF N/A
  • AVG Volume (30 Days)
  • NOTV 512.6K
  • PNF 29.1K
  • Earning Date
  • NOTV 08-07-2025
  • PNF 01-01-0001
  • Dividend Yield
  • NOTV N/A
  • PNF 5.17%
  • EPS Growth
  • NOTV N/A
  • PNF N/A
  • EPS
  • NOTV N/A
  • PNF N/A
  • Revenue
  • NOTV $480,402,000.00
  • PNF N/A
  • Revenue This Year
  • NOTV $4.99
  • PNF N/A
  • Revenue Next Year
  • NOTV $5.39
  • PNF N/A
  • P/E Ratio
  • NOTV N/A
  • PNF N/A
  • Revenue Growth
  • NOTV N/A
  • PNF N/A
  • 52 Week Low
  • NOTV $1.15
  • PNF $6.37
  • 52 Week High
  • NOTV $6.48
  • PNF $9.06
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 49.04
  • PNF 53.66
  • Support Level
  • NOTV $2.06
  • PNF $6.96
  • Resistance Level
  • NOTV $2.30
  • PNF $7.08
  • Average True Range (ATR)
  • NOTV 0.17
  • PNF 0.06
  • MACD
  • NOTV 0.02
  • PNF 0.01
  • Stochastic Oscillator
  • NOTV 70.31
  • PNF 57.89

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About PNF PIMCO New York Municipal Income Fund

PIMCO New York Municipal Income Fund is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund's portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.

Share on Social Networks: